Xconomy: Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision

[cafead]

via By next weekend, the FDA could for the first time approve a medicine that uses a biological trick that was only discovered two decades ago: RNA interference, which silences a gene before it can make a harmful protein. That medicine is patisiran (Onpattro), from Alnylam Pharmaceuticals.

article source